Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Buy
53
MGTX Quote, Financials, Valuation and Earnings
Last price:
$8.60
Seasonality move
:
5.84%
Day range:
$8.29 - $9.15
52-week range:
$4.55 - $9.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
25.89x
P/B ratio:
222.74x
Volume:
685.9K
Avg. volume:
656.8K
1-year change:
45.42%
Market cap:
$716.4M
Revenue:
$33.3M
EPS (TTM):
-$2.11
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MGTX
MeiraGTx Holdings Plc
|
$7M | -$0.49 | -81.58% | -23.36% | $27.50 |
|
ALEC
Alector, Inc.
|
$3.5M | -$0.41 | -96.49% | -1693.03% | $2.05 |
|
GOSS
Gossamer Bio, Inc.
|
$6.4M | -$0.20 | -19.8% | -31.46% | $9.50 |
|
LLY
Eli Lilly & Co.
|
$16.1B | $5.89 | 31.31% | 54.32% | $1,075.07 |
|
URGN
UroGen Pharma Ltd.
|
$32.5M | -$0.68 | 68.74% | -38.75% | $35.25 |
|
VYGR
Voyager Therapeutics, Inc.
|
$7.9M | -$0.52 | 67.16% | -13.57% | $15.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MGTX
MeiraGTx Holdings Plc
|
$8.90 | $27.50 | $716.4M | -- | $0.00 | 0% | 25.89x |
|
ALEC
Alector, Inc.
|
$1.39 | $2.05 | $151.7M | -- | $0.00 | 0% | 2.02x |
|
GOSS
Gossamer Bio, Inc.
|
$3.79 | $9.50 | $877.2M | -- | $0.00 | 0% | 19.54x |
|
LLY
Eli Lilly & Co.
|
$1,062.19 | $1,075.07 | $950.7B | 52.53x | $1.50 | 0.57% | 16.30x |
|
URGN
UroGen Pharma Ltd.
|
$22.85 | $35.25 | $1.1B | -- | $0.00 | 0% | 11.26x |
|
VYGR
Voyager Therapeutics, Inc.
|
$4.36 | $15.00 | $242.4M | 6.11x | $0.00 | 0% | 8.14x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MGTX
MeiraGTx Holdings Plc
|
185.38% | 0.506 | 13.3% | 0.12x |
|
ALEC
Alector, Inc.
|
39.62% | 3.270 | 11.91% | 3.64x |
|
GOSS
Gossamer Bio, Inc.
|
168.3% | 0.636 | 33.35% | 3.05x |
|
LLY
Eli Lilly & Co.
|
64.11% | -0.293 | 6.22% | 0.65x |
|
URGN
UroGen Pharma Ltd.
|
894.17% | 4.259 | 13.92% | 3.51x |
|
VYGR
Voyager Therapeutics, Inc.
|
14.86% | 2.251 | 14.81% | 5.98x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MGTX
MeiraGTx Holdings Plc
|
-$3.1M | -$46.1M | -145.42% | -530.25% | -11231.95% | -$12.8M |
|
ALEC
Alector, Inc.
|
$928K | -$37.7M | -81.03% | -114.8% | -1156.69% | -$32.5M |
|
GOSS
Gossamer Bio, Inc.
|
$13.1M | -$41.6M | -81% | -615% | -313.21% | -$36.2M |
|
LLY
Eli Lilly & Co.
|
$14.6B | $8.4B | 33.81% | 106.26% | 47.65% | $6B |
|
URGN
UroGen Pharma Ltd.
|
$24.2M | -$27.4M | -209.52% | -- | -99.65% | -$47.6M |
|
VYGR
Voyager Therapeutics, Inc.
|
$12.4M | -$30.6M | -40.22% | -46.39% | -228.91% | -$31.3M |
MeiraGTx Holdings Plc vs. Competitors
-
Which has Higher Returns MGTX or ALEC?
Alector, Inc. has a net margin of -12320.24% compared to MeiraGTx Holdings Plc's net margin of -1063.41%. MeiraGTx Holdings Plc's return on equity of -530.25% beat Alector, Inc.'s return on equity of -114.8%.
Company Gross Margin Earnings Per Share Invested Capital MGTXMeiraGTx Holdings Plc-746.1% -$0.62 $47.5M ALECAlector, Inc.28.47% -$0.34 $95.6M -
What do Analysts Say About MGTX or ALEC?
MeiraGTx Holdings Plc has a consensus price target of $27.50, signalling upside risk potential of 208.99%. On the other hand Alector, Inc. has an analysts' consensus of $2.05 which suggests that it could grow by 47.48%. Given that MeiraGTx Holdings Plc has higher upside potential than Alector, Inc., analysts believe MeiraGTx Holdings Plc is more attractive than Alector, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MGTXMeiraGTx Holdings Plc6 0 0 ALECAlector, Inc.1 6 1 -
Is MGTX or ALEC More Risky?
MeiraGTx Holdings Plc has a beta of 1.384, which suggesting that the stock is 38.351% more volatile than S&P 500. In comparison Alector, Inc. has a beta of 0.667, suggesting its less volatile than the S&P 500 by 33.287%.
-
Which is a Better Dividend Stock MGTX or ALEC?
MeiraGTx Holdings Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alector, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MeiraGTx Holdings Plc pays -- of its earnings as a dividend. Alector, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MGTX or ALEC?
MeiraGTx Holdings Plc quarterly revenues are $410K, which are smaller than Alector, Inc. quarterly revenues of $3.3M. MeiraGTx Holdings Plc's net income of -$50.5M is lower than Alector, Inc.'s net income of -$34.7M. Notably, MeiraGTx Holdings Plc's price-to-earnings ratio is -- while Alector, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MeiraGTx Holdings Plc is 25.89x versus 2.02x for Alector, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MGTXMeiraGTx Holdings Plc25.89x -- $410K -$50.5M ALECAlector, Inc.2.02x -- $3.3M -$34.7M
-
Which has Higher Returns MGTX or GOSS?
Gossamer Bio, Inc. has a net margin of -12320.24% compared to MeiraGTx Holdings Plc's net margin of -362.73%. MeiraGTx Holdings Plc's return on equity of -530.25% beat Gossamer Bio, Inc.'s return on equity of -615%.
Company Gross Margin Earnings Per Share Invested Capital MGTXMeiraGTx Holdings Plc-746.1% -$0.62 $47.5M GOSSGossamer Bio, Inc.98.35% -$0.21 $120.5M -
What do Analysts Say About MGTX or GOSS?
MeiraGTx Holdings Plc has a consensus price target of $27.50, signalling upside risk potential of 208.99%. On the other hand Gossamer Bio, Inc. has an analysts' consensus of $9.50 which suggests that it could grow by 150.66%. Given that MeiraGTx Holdings Plc has higher upside potential than Gossamer Bio, Inc., analysts believe MeiraGTx Holdings Plc is more attractive than Gossamer Bio, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MGTXMeiraGTx Holdings Plc6 0 0 GOSSGossamer Bio, Inc.6 1 0 -
Is MGTX or GOSS More Risky?
MeiraGTx Holdings Plc has a beta of 1.384, which suggesting that the stock is 38.351% more volatile than S&P 500. In comparison Gossamer Bio, Inc. has a beta of 1.921, suggesting its more volatile than the S&P 500 by 92.071%.
-
Which is a Better Dividend Stock MGTX or GOSS?
MeiraGTx Holdings Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Gossamer Bio, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MeiraGTx Holdings Plc pays -- of its earnings as a dividend. Gossamer Bio, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MGTX or GOSS?
MeiraGTx Holdings Plc quarterly revenues are $410K, which are smaller than Gossamer Bio, Inc. quarterly revenues of $13.3M. MeiraGTx Holdings Plc's net income of -$50.5M is lower than Gossamer Bio, Inc.'s net income of -$48.2M. Notably, MeiraGTx Holdings Plc's price-to-earnings ratio is -- while Gossamer Bio, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MeiraGTx Holdings Plc is 25.89x versus 19.54x for Gossamer Bio, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MGTXMeiraGTx Holdings Plc25.89x -- $410K -$50.5M GOSSGossamer Bio, Inc.19.54x -- $13.3M -$48.2M
-
Which has Higher Returns MGTX or LLY?
Eli Lilly & Co. has a net margin of -12320.24% compared to MeiraGTx Holdings Plc's net margin of 31.72%. MeiraGTx Holdings Plc's return on equity of -530.25% beat Eli Lilly & Co.'s return on equity of 106.26%.
Company Gross Margin Earnings Per Share Invested Capital MGTXMeiraGTx Holdings Plc-746.1% -$0.62 $47.5M LLYEli Lilly & Co.82.91% $6.21 $66.4B -
What do Analysts Say About MGTX or LLY?
MeiraGTx Holdings Plc has a consensus price target of $27.50, signalling upside risk potential of 208.99%. On the other hand Eli Lilly & Co. has an analysts' consensus of $1,075.07 which suggests that it could grow by 1.21%. Given that MeiraGTx Holdings Plc has higher upside potential than Eli Lilly & Co., analysts believe MeiraGTx Holdings Plc is more attractive than Eli Lilly & Co..
Company Buy Ratings Hold Ratings Sell Ratings MGTXMeiraGTx Holdings Plc6 0 0 LLYEli Lilly & Co.17 8 0 -
Is MGTX or LLY More Risky?
MeiraGTx Holdings Plc has a beta of 1.384, which suggesting that the stock is 38.351% more volatile than S&P 500. In comparison Eli Lilly & Co. has a beta of 0.370, suggesting its less volatile than the S&P 500 by 62.965%.
-
Which is a Better Dividend Stock MGTX or LLY?
MeiraGTx Holdings Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Eli Lilly & Co. offers a yield of 0.57% to investors and pays a quarterly dividend of $1.50 per share. MeiraGTx Holdings Plc pays -- of its earnings as a dividend. Eli Lilly & Co. pays out 44.39% of its earnings as a dividend. Eli Lilly & Co.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MGTX or LLY?
MeiraGTx Holdings Plc quarterly revenues are $410K, which are smaller than Eli Lilly & Co. quarterly revenues of $17.6B. MeiraGTx Holdings Plc's net income of -$50.5M is lower than Eli Lilly & Co.'s net income of $5.6B. Notably, MeiraGTx Holdings Plc's price-to-earnings ratio is -- while Eli Lilly & Co.'s PE ratio is 52.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MeiraGTx Holdings Plc is 25.89x versus 16.30x for Eli Lilly & Co.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MGTXMeiraGTx Holdings Plc25.89x -- $410K -$50.5M LLYEli Lilly & Co.16.30x 52.53x $17.6B $5.6B
-
Which has Higher Returns MGTX or URGN?
UroGen Pharma Ltd. has a net margin of -12320.24% compared to MeiraGTx Holdings Plc's net margin of -121.34%. MeiraGTx Holdings Plc's return on equity of -530.25% beat UroGen Pharma Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MGTXMeiraGTx Holdings Plc-746.1% -$0.62 $47.5M URGNUroGen Pharma Ltd.88.07% -$0.69 $14.5M -
What do Analysts Say About MGTX or URGN?
MeiraGTx Holdings Plc has a consensus price target of $27.50, signalling upside risk potential of 208.99%. On the other hand UroGen Pharma Ltd. has an analysts' consensus of $35.25 which suggests that it could grow by 54.27%. Given that MeiraGTx Holdings Plc has higher upside potential than UroGen Pharma Ltd., analysts believe MeiraGTx Holdings Plc is more attractive than UroGen Pharma Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MGTXMeiraGTx Holdings Plc6 0 0 URGNUroGen Pharma Ltd.6 1 0 -
Is MGTX or URGN More Risky?
MeiraGTx Holdings Plc has a beta of 1.384, which suggesting that the stock is 38.351% more volatile than S&P 500. In comparison UroGen Pharma Ltd. has a beta of 1.214, suggesting its more volatile than the S&P 500 by 21.395%.
-
Which is a Better Dividend Stock MGTX or URGN?
MeiraGTx Holdings Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UroGen Pharma Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MeiraGTx Holdings Plc pays -- of its earnings as a dividend. UroGen Pharma Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MGTX or URGN?
MeiraGTx Holdings Plc quarterly revenues are $410K, which are smaller than UroGen Pharma Ltd. quarterly revenues of $27.5M. MeiraGTx Holdings Plc's net income of -$50.5M is lower than UroGen Pharma Ltd.'s net income of -$33.3M. Notably, MeiraGTx Holdings Plc's price-to-earnings ratio is -- while UroGen Pharma Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MeiraGTx Holdings Plc is 25.89x versus 11.26x for UroGen Pharma Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MGTXMeiraGTx Holdings Plc25.89x -- $410K -$50.5M URGNUroGen Pharma Ltd.11.26x -- $27.5M -$33.3M
-
Which has Higher Returns MGTX or VYGR?
Voyager Therapeutics, Inc. has a net margin of -12320.24% compared to MeiraGTx Holdings Plc's net margin of -208.69%. MeiraGTx Holdings Plc's return on equity of -530.25% beat Voyager Therapeutics, Inc.'s return on equity of -46.39%.
Company Gross Margin Earnings Per Share Invested Capital MGTXMeiraGTx Holdings Plc-746.1% -$0.62 $47.5M VYGRVoyager Therapeutics, Inc.93.03% -$0.47 $258.2M -
What do Analysts Say About MGTX or VYGR?
MeiraGTx Holdings Plc has a consensus price target of $27.50, signalling upside risk potential of 208.99%. On the other hand Voyager Therapeutics, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 244.04%. Given that Voyager Therapeutics, Inc. has higher upside potential than MeiraGTx Holdings Plc, analysts believe Voyager Therapeutics, Inc. is more attractive than MeiraGTx Holdings Plc.
Company Buy Ratings Hold Ratings Sell Ratings MGTXMeiraGTx Holdings Plc6 0 0 VYGRVoyager Therapeutics, Inc.12 0 0 -
Is MGTX or VYGR More Risky?
MeiraGTx Holdings Plc has a beta of 1.384, which suggesting that the stock is 38.351% more volatile than S&P 500. In comparison Voyager Therapeutics, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.615%.
-
Which is a Better Dividend Stock MGTX or VYGR?
MeiraGTx Holdings Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Voyager Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MeiraGTx Holdings Plc pays -- of its earnings as a dividend. Voyager Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MGTX or VYGR?
MeiraGTx Holdings Plc quarterly revenues are $410K, which are smaller than Voyager Therapeutics, Inc. quarterly revenues of $13.4M. MeiraGTx Holdings Plc's net income of -$50.5M is lower than Voyager Therapeutics, Inc.'s net income of -$27.9M. Notably, MeiraGTx Holdings Plc's price-to-earnings ratio is -- while Voyager Therapeutics, Inc.'s PE ratio is 6.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MeiraGTx Holdings Plc is 25.89x versus 8.14x for Voyager Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MGTXMeiraGTx Holdings Plc25.89x -- $410K -$50.5M VYGRVoyager Therapeutics, Inc.8.14x 6.11x $13.4M -$27.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
71
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
39
SMX alert for Dec 16
SMX (Security Matters) Plc [SMX] is down 18.2% over the past day.
Sell
33
ZBIO alert for Dec 16
Zenas BioPharma, Inc. [ZBIO] is up 13.35% over the past day.
Sell
38
HUT alert for Dec 16
Hut 8 Corp. [HUT] is up 3.92% over the past day.
